143 related articles for article (PubMed ID: 31848027)
1. Severe myocarditis with slight lymphocytic infiltration after nivolumab treatment.
Edahiro R; Shiroyama T; Hijiki S; Nojima S; Shirai Y; Koyama S; Kumanogoh A
Lung Cancer; 2020 Feb; 140():116-117. PubMed ID: 31848027
[No Abstract] [Full Text] [Related]
2. Combined checkpoint inhibitor-associated myocarditis and pulmonary vasculitis mimicking acute pulmonary embolism.
Baldetti L; Melillo F; Beneduce A; Camici PG
Eur Heart J Cardiovasc Imaging; 2019 Feb; 20(2):243. PubMed ID: 30535006
[No Abstract] [Full Text] [Related]
3. [Fulminant myocarditis caused by nivolumab treatment for non-small cell lung cancer (NSCLC): a case report].
Tan KX; Li CY; Zhang JY; Cui HJ; Shen W; Zhang X; Sun CY; Jiang XJ; Zheng SY; Li J; Xue CX
Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1047-1048. PubMed ID: 33342162
[No Abstract] [Full Text] [Related]
4. Immunotherapy- A double Edged Sword; A case of Fatal Myocarditis and Complete Response.
Peters N; Greally M; Breen K; Fabre A; Blazkova S
Ir Med J; 2019 May; 112(5):937. PubMed ID: 31411390
[No Abstract] [Full Text] [Related]
5. Fatal association of fulminant myocarditis and rhabdomyolysis after immune checkpoint blockade.
Tomoaia R; Beyer RȘ; Pop D; Minciună IA; Dădârlat-Pop A
Eur J Cancer; 2020 Jun; 132():224-227. PubMed ID: 32336614
[No Abstract] [Full Text] [Related]
6. Development of mild drug-induced sclerosing cholangitis after discontinuation of nivolumab.
Noda-Narita S; Mizuno S; Noguchi S; Watanabe K; Nakai Y; Koike K; Kage H; Nagase T
Eur J Cancer; 2019 Jan; 107():93-96. PubMed ID: 30554074
[No Abstract] [Full Text] [Related]
7. Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings.
Imai R; Ono M; Nishimura N; Suzuki K; Komiyama N; Tamura T
J Thorac Oncol; 2019 Feb; 14(2):e36-e38. PubMed ID: 30391574
[No Abstract] [Full Text] [Related]
8. Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding.
Dall'Olio FG; Sperandi F; Rihawi K; Gargiulo M; Melotti B; Brocchi S; Gelsomino F; Ardizzoni A
J Thorac Oncol; 2018 Dec; 13(12):e247-e248. PubMed ID: 30467045
[No Abstract] [Full Text] [Related]
9. Nivolumab-induced Pancreatitis: An Immune-related Adverse Event.
Saito H; Ono K
Radiology; 2019 Dec; 293(3):521. PubMed ID: 31617817
[No Abstract] [Full Text] [Related]
10. Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.
Salem JE; Allenbach Y; Vozy A; Brechot N; Johnson DB; Moslehi JJ; Kerneis M
N Engl J Med; 2019 Jun; 380(24):2377-2379. PubMed ID: 31189043
[No Abstract] [Full Text] [Related]
11. [Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review].
Prevel R; Colin G; Calès V; Renault PA; Mazieres J
Rev Med Interne; 2020 Apr; 41(4):284-288. PubMed ID: 31983550
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint inhibitors myocarditis: not all cases are clinically patent.
Thibault C; Vano Y; Soulat G; Mirabel M
Eur Heart J; 2018 Oct; 39(38):3553. PubMed ID: 30107497
[No Abstract] [Full Text] [Related]
13. Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature.
Veccia A; Kinspergher S; Grego E; Peterlana D; Berti A; Tranquillini E; Caffo O
Anticancer Drugs; 2020 Jun; 31(5):540-544. PubMed ID: 32011360
[TBL] [Abstract][Full Text] [Related]
14. Three cases of immune cholangitis related to anti-programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer.
Fouchard M; Jantzem H; Quere G; Descourt R; Robinet G; Poureau PG
Eur J Cancer; 2019 Jul; 115():107-110. PubMed ID: 31132740
[No Abstract] [Full Text] [Related]
15. Nivolumab-induced myocarditis complicated by complete atrioventricular block in a patient with metastatic non-small cell lung cancer.
Tan JL; Mugwagwa AN; Cieslik L; Joshi R
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31300602
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(4):263b. PubMed ID: 29176295
[No Abstract] [Full Text] [Related]
17. Spontaneous hematoma of the thigh associated with antiproteinase-3 antibody in a patient with metastatic squamous cell carcinoma treated with nivolumab.
Keung YK; Hu EH
J Oncol Pharm Pract; 2019 Jul; 25(5):1261-1264. PubMed ID: 29984627
[TBL] [Abstract][Full Text] [Related]
18. Nivolumab-associated Stevens-Johnson syndrome in a patient with lung cancer.
Gracia-Cazaña T; Padgett E; Calderero V; Oncins R
Dermatol Online J; 2021 Mar; 27(3):. PubMed ID: 33865285
[TBL] [Abstract][Full Text] [Related]
19. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung.
Semper H; Muehlberg F; Schulz-Menger J; Allewelt M; Grohé C
Lung Cancer; 2016 Sep; 99():117-9. PubMed ID: 27565924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
